Key facts
- This page summarizes Steve E. Krognes's Form 3 filing for PLIANT THERAPEUTICS, INC. (PLRX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 17 Jun 2024, 19:52.
Steve E. Krognes - 13 Jun 2024 Form 3 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)
- Reporting relationship
- Director
- Issuer ticker
- PLRX
- Reported as of
- 13 Jun 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 17 Jun 2024, 19:52:27 UTC
- Prior SEC filing
- 13 Jun 2024
- Next SEC filing
- 02 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jennifer Woo, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Steve E. Krognes filed Form 3 for PLIANT THERAPEUTICS, INC. (PLRX) on 17 Jun 2024.
Change
- Previous filing in this sequence was filed on 13 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.